1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. E-therapeutics plc
  6. News
  7. Press Releases
    ETX   GB00B2823H99

E-THERAPEUTICS PLC

(ETX)
  Report
Delayed London Stock Exchange  -  05/20 11:35:09 am EDT
19.48 GBX   -3.11%
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Revenue GBP477,000
MT
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Loss GBX-1.65
MT
05/04E-therapeutics plc Announces Change of Registered Office
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société E-THERAPEUTICS PLC
2021Director Dealing – 26th October 2021
PU
2021E THERAPEUTICS : Interim Results, July 2021 and RNAi Platform Development Presentation
PU
2021E THERAPEUTICS : Interim results for six months ended 31 July 2021
PU
2021E THERAPEUTICS : RNAi Platform Characterisation Results
PU
2021E THERAPEUTICS : Patent Filings – October 2021
PU
2021E THERAPEUTICS : Notice of Interim Results 2021
PU
2021E THERAPEUTICS : Commencement of trading on the OTCQX Best Market in the United States
PU
2021E THERAPEUTICS : Director Dealing and Issue of Equity
PU
2021E THERAPEUTICS : Further milestone in Galapagos collaboration
PU
2021E THERAPEUTICS : 2021 AGM Proxy Results
PU
2021E THERAPEUTICS : Senior Management Appointment and Grant of Options
PU
2021E THERAPEUTICS : Notice of Annual General Meeting and Posting of Annual Report and Account..
PU
2021E THERAPEUTICS : Annual Report for the year ended 31 January 2021
PU
2021E THERAPEUTICS : Final Results for the Year Ended 31 January 2021
PU
2021E THERAPEUTICS : to receive two key milestone payments from Galapagos
PU
2021E THERAPEUTICS : Appointment of Chief Financial Officer
PU
2021E THERAPEUTICS : RNA Therapeutics Platform Announced
PU
2020E THERAPEUTICS : COVID-19 Project Update
PU
2020E THERAPEUTICS : Board Changes and Placing
PU
2018E THERAPEUTICS : Research Collaboration Agreement with Novo Nordisk
PU
2018E THERAPEUTICS : and C4X Collaboration
PU
2018E THERAPEUTICS : Drug Discovery Innovation Programme Presentation
PU
2018E THERAPEUTICS : Interim Results for six months ended 31 July 2018
PU
2018E THERAPEUTICS : Notice of Interim Results
PU
2018E THERAPEUTICS : Director Shareholding
PU
2018E THERAPEUTICS : Collaboration with C4X Discovery Holdings PLC
PU
2018E-THERAPEUTICS PLC : Full Year Results
BU
2018E THERAPEUTICS : Director/PDMR Shareholding
PU
2018E THERAPEUTICS : enters two AI collaborations
PU
2017E THERAPEUTICS : Director/PDMR Shareholding
PU
2017E THERAPEUTICS : Appointment of Director
PU
2017E THERAPEUTICS : Interim Results for 6 Months Ended 31 July 2017
PU
2017E-THERAPEUTICS : Announces Outcome of Strategic Review and Future Plans
BU
2017E THERAPEUTICS : Notification by Director
PU
2017E THERAPEUTICS : Notice of Annual General Meeting and Annual Report
PU
2017E THERAPEUTICS : Final Results
PU
2017E-THERAPEUTICS PLC : Appointment of Chief Executive Officer
BU
2017E THERAPEUTICS : Notification of Full Year Results Date
PU
2017E THERAPEUTICS : New CEO Commences at e-Therapeutics
PU
2017E THERAPEUTICS : Appointment of CEO
PU
2016E THERAPEUTICS : Grant of share options and Directors' dealings
PU
2016E THERAPEUTICS : Directors' Dealings and Issue of Equity
PU
2016FURTHER RE : Directors' Shareholdings
PU
2016E THERAPEUTICS : Issue of Equity and Directors' shareholdings
PU
2016E THERAPEUTICS : Half year results
PU
2016E THERAPEUTICS : Management Update
PU
2016E THERAPEUTICS : Notice of Half Year Results
PU
2016E THERAPEUTICS : Holding(s) in Company – Correction
PU
2016E THERAPEUTICS : Issue of Equity
PU
2016E THERAPEUTICS : Board changes
PU
2016E THERAPEUTICS : Issue of Equity and Directors' shareholdings
PU
2016E THERAPEUTICS : Searchbolt Offer becomes wholly unconditional
PU
2016E THERAPEUTICS : Result of General Meeting
PU
2016E THERAPEUTICS : AGM Statement
PU
2016GRIDGAIN : Helps e-Therapeutics Find Treatments for Biocomplex Diseases
MW
2016E THERAPEUTICS : Notice of General Meeting – Correction
PU
2016E THERAPEUTICS : Notice of AGM and Annual Report
PU
2016E THERAPEUTICS : Strategic Prioritisation on Discovery Platform and Commercialisation
BU
2016E THERAPEUTICS : Notice of Results
PU
2016E THERAPEUTICS : Top-line Phase IIb results update
PU
2016E THERAPEUTICS : Appointment of Non-Executive Chairman
PU
2015E THERAPEUTICS : Discovery Platform Exceeding Expectations; Company Focus Now on Commercia..
BU
2015E THERAPEUTICS : Notice of half year results
PU
2015E THERAPEUTICS : Change of Nominated Advisor and Broker
PU
2015E THERAPEUTICS : Director's disclosure
PU
2015E THERAPEUTICS : Half year trading and commercial strategy update
PU
2015E THERAPEUTICS : Additional listing
PU
2015E THERAPEUTICS : Results of Annual General Meeting
PU
2015E THERAPEUTICS : Progress in ETS2101 Phase Ib Study
PU
2015E THERAPEUTICS : Notice of Annual General Meeting and Annual Report
PU
2015E THERAPEUTICS : Announces Full Year Results
BU
2015E THERAPEUTICS : Notification of Full Year Results Date
PU
2015E THERAPEUTICS : Notification of Major Interest in Shares
PU
2015E THERAPEUTICS : Share price movement
PU
2015E THERAPEUTICS : Director/PDMR Shareholding
PU
1  2  3Next
Upcoming event on E-THERAPEUTICS PLC